4//SEC Filing
IMPAX LABORATORIES INC 4
Accession 0001437749-12-011928
CIK 0001003642operating
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:55 PM ET
Size
5.1 KB
Accession
0001437749-12-011928
Insider Transaction Report
Form 4
MARKBREITER MICHAEL
Director
Transactions
- Sale
Common Stock
2012-11-16$19.73/sh−6,667$131,540→ 7,999 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $19.67 to $19.83 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
IMPAX LABORATORIES INC
CIK 0001003642
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001003642
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 6:55 PM ET
- Size
- 5.1 KB